OSE Immunotherapeutics – equity proposition

OSE Immunotherapeutics – equity proposition

OSE Immunotherapeutics — 9 videos in collection

More on this equity

OSE Immunotherapeutics (PAR:OSE) is based in Nantes and Paris in France and is listed on the Euronext Paris exchange.

There are five key reasons why OSE may be considered an attractive investment.

  1. OSE has a diverse pipeline of assets, backed by science at the forefront of immunotherapy research, offering multiple shots at goal.
  2. OSE has a track record of partnering with pharma players.
  3. OSE is a platform company with four cutting-edge preclinical platforms offering broad potential to create a diverse pipeline of first-in-class therapies with a host of applications.
  4. The company is led by a highly experienced executive leadership team with a proven track record in drug development and business execution.
  5. OSE has a robust financial position and an attractive outlook for growth.

If you would like to learn more about OSE Immunotherapeutics, please see our latest research here.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.